产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
CAS No. |
2369751-07-3 |
|---|---|
中文名称 |
1-(6,7-二氯-9-(1-甲基-1H-吡唑-3-基)-3,4-二氢-1H-吡啶并[4,3-b]吲哚-2(5H)-基)-2-羟基乙酮 |
英文名称 |
1-(6,7-Dichloro-9-(1-methyl-1H-pyrazol-3-yl)-3,4-dihydro-1H-pyrido[4,3-b]indol-2(5H)-yl)-2-hydroxyethanone |
别名 |
Ethanone, 1-[6,7-dichloro-1,3,4,5-tetrahydro-9-(1-methyl-1H-pyrazol-3-yl)-2H-pyrido[4,3-b]indol-2-yl]-2-hydroxy-;G140;pegcetacoplan(APL-2),G140;Inhibitor,cGAS,anti-inflammatory,G 140,Cyclic GMP-AMP Synthase,G140,synthase,G-140,GMP-AMP,cyclic,inhibit;1-(6,7-Dichloro-9-(1-methyl-1H-pyrazol-3-yl)-3,4-dihydro-1H-pyrido[4,3-b]indol-2(5H)-yl)-2-hydroxyethanone;G140, 10 mM in DMSO |
标准英文名 |
1-(6,7-dichloro-9-(1-methyl-1H-pyrazol-3-yl)-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)-2-hydroxyethan-1-one |
MDL No. |
MFCD34368516 |
分子式 |
C17H16Cl2N4O2 |
分子量 |
379.25 |
精确分子量 |
378.07 |
SMILES |
OCC(N(C1)CCC(N2)=C1C3=C2C(Cl)=C(Cl)C=C3C4=NN(C)C=C4)=O |
标准SMILES |
CN1C=CC(=N1)C1=CC(Cl)=C(Cl)C2NC3CCN(CC=3C1=2)C(=O)CO |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
NVPFAXHXXODQRO-UHFFFAOYSA-N |
危险类别(旧) |
H302 |
存储要求 |
Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral,Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|